BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12726854)

  • 1. p53 mutations and resistance to chemotherapy: A stab in the back for p73.
    Soussi T
    Cancer Cell; 2003 Apr; 3(4):303-5. PubMed ID: 12726854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [p53 mutations and resistance to chemotherapy: a stab in the back for p73?].
    Soussi T
    Bull Cancer; 2003 May; 90(5):383-6. PubMed ID: 12850759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p73.
    Davis PK; Dowdy SF
    Int J Biochem Cell Biol; 2001 Oct; 33(10):935-9. PubMed ID: 11470228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p73: Friend or foe in tumorigenesis.
    Melino G; De Laurenzi V; Vousden KH
    Nat Rev Cancer; 2002 Aug; 2(8):605-15. PubMed ID: 12154353
    [No Abstract]   [Full Text] [Related]  

  • 5. p73 cooperates with DNA damage agents to induce apoptosis in MCF7 cells in a p53-dependent manner.
    Zhu J; Nozell S; Wang J; Jiang J; Zhou W; Chen X
    Oncogene; 2001 Jul; 20(30):4050-7. PubMed ID: 11494133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemosensitivity linked to p73 function.
    Irwin MS; Kondo K; Marin MC; Cheng LS; Hahn WC; Kaelin WG
    Cancer Cell; 2003 Apr; 3(4):403-10. PubMed ID: 12726865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNp73 a matter of cancer: mechanisms and clinical implications.
    Buhlmann S; Pützer BM
    Biochim Biophys Acta; 2008 Apr; 1785(2):207-16. PubMed ID: 18302944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo.
    Concin N; Hofstetter G; Berger A; Gehmacher A; Reimer D; Watrowski R; Tong D; Schuster E; Hefler L; Heim K; Mueller-Holzner E; Marth C; Moll UM; Zeimet AG; Zeillinger R
    Clin Cancer Res; 2005 Dec; 11(23):8372-83. PubMed ID: 16322298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p73, the "assistant" guardian of the genome?
    Melino G
    Ann N Y Acad Sci; 2003 Dec; 1010():9-15. PubMed ID: 15033688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Family feud in chemosensitvity: p73 and mutant p53.
    Irwin MS
    Cell Cycle; 2004 Mar; 3(3):319-23. PubMed ID: 14739781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential tumor suppressor p73 differentially regulates cellular p53 target genes.
    Zhu J; Jiang J; Zhou W; Chen X
    Cancer Res; 1998 Nov; 58(22):5061-5. PubMed ID: 9823311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p73 or p53 directly regulates human p53 transcription to maintain cell cycle checkpoints.
    Wang S; El-Deiry WS
    Cancer Res; 2006 Jul; 66(14):6982-9. PubMed ID: 16849542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of p73 in malignancy: tumor suppressor or oncogene?
    Stiewe T; Pützer BM
    Cell Death Differ; 2002 Mar; 9(3):237-45. PubMed ID: 11859406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation analysis of the p51 gene and correlation between p53, p73, and p51 expressions in prostatic carcinoma.
    Takahashi H; Fukutome K; Watanabe M; Furusato M; Shiraishi T; Ito H; Suzuki H; Ikawa S; Hano H
    Prostate; 2001 May; 47(2):85-90. PubMed ID: 11340630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 family update: p73 and p63 develop their own identities.
    Irwin MS; Kaelin WG
    Cell Growth Differ; 2001 Jul; 12(7):337-49. PubMed ID: 11457731
    [No Abstract]   [Full Text] [Related]  

  • 16. The p53 homology trap.
    Knight RA; Candi E; Melino G
    Cancer Biol Ther; 2003; 2(1):63-6. PubMed ID: 12673119
    [No Abstract]   [Full Text] [Related]  

  • 17. p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis.
    Bergamaschi D; Gasco M; Hiller L; Sullivan A; Syed N; Trigiante G; Yulug I; Merlano M; Numico G; Comino A; Attard M; Reelfs O; Gusterson B; Bell AK; Heath V; Tavassoli M; Farrell PJ; Smith P; Lu X; Crook T
    Cancer Cell; 2003 Apr; 3(4):387-402. PubMed ID: 12726864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53: emergency brake and target for cancer therapy.
    Wiman KG
    Exp Cell Res; 1997 Nov; 237(1):14-8. PubMed ID: 9417861
    [No Abstract]   [Full Text] [Related]  

  • 19. The emerging p53 gene family.
    Kaelin WG
    J Natl Cancer Inst; 1999 Apr; 91(7):594-8. PubMed ID: 10203277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes.
    Costanzo A; Merlo P; Pediconi N; Fulco M; Sartorelli V; Cole PA; Fontemaggi G; Fanciulli M; Schiltz L; Blandino G; Balsano C; Levrero M
    Mol Cell; 2002 Jan; 9(1):175-86. PubMed ID: 11804596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.